Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111
datasets available to search
ShareScore release 0.9.0
Dataset results
111 results for “IMC”
A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors
ClinicalTrials.gov study NCT01515306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
ClinicalTrials.gov study NCT01634555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
ClinicalTrials.gov study NCT00781911. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
ClinicalTrials.gov study NCT00870870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD14+ IMC treated TGF-beta
GEO Series GSE96885. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
Human bone marrow IMC dataset and simulation dataset
<p>Human bone marrow IMC dataset and simulation dataset in the paper: IMC-Denoise: a content aware pipeline to enhance Imaging Mass Cytometry. For more details, please check this paper.</p>
Results of IMC-Denoise: a content aware pipeline to enhance Imaging Mass Cytometry
<ul> <li>Generated training sets: <ul> <li>training_set_supp_table6.zip</li> <li>training_set_supp_table7.zip</li> <li>training_set_supp_table8.zip</li> <li>training_set_supp_table9.zip</li> <li>training_set_supp_table10.zip</li> <li>training_set_supp_table11.zip</li> </ul> </li> <li>Trained weights of experimental data: <ul> <li>training_result_supp_table7.zip</li> <li>training_result_supp_table8.zip</li> <li>training_result_supp_table9.zip</li> <li>training_result_supp_table10.zip</li> <li>training_result_supp_table11.zip</li> </ul> </li> <li>Simulation results: <ul> <li>Simulation_results.zip</li> </ul> </li> <li>Experimental results: <ul> <li>Human_bone_marrow_IMC_denoising_results.zip</li> <li>Human_breast_cancer_IMC_denoising_results.zip</li> <li>Human_pancreatic_cancer_IMC_denoising_results.zip</li> <li>MIBI_denoising_results.zip</li> </ul> </li> <li>Ilastik-processed or manual-labeled results: <ul> <li>DIMR_Ilastik_results.zip</li> <li>background_removal_results.zip</li> <li>manual_annotated_public_datasets.zip</li> </ul> </li> <li>Extracted single cell data and the corresponding phenotyping results from both DIMR and DeepSNiF-based segmented cell masks: <ul> <li>Single_cell_analysis.zip</li> </ul> </li> </ul>
IMC dataset for CCA mouse model study
<p>Imaging Mass Cytometry files acquired at Johns Hopkins Mass Cytometry Facility</p> <p>Contents of zipped file, "Raw_MCDFiles_Manuscript.zip":</p> <ol> <li>Raw MCD files for cholangiocarcinoma mouse model study</li> <li>Metadata for ROIs</li> </ol> <p>Also included, "IMC - Mouse Panel": panel of antibodies used</p> <p>Notes:</p> <ul> <li>ROI D2 was split into two ROIs: D2-split1 and D2-split2</li> <li>Non-experimental ROIs are labelled as either “null” or “Energy Test”</li> </ul>
Single cell alloimmune landscape of liver transplant rejection IMC data
<p>This contains 23 raw .mcd files obtained using IMC, the key markers used during downstream analysis, a metadata_samples.csv file with the clinical group identifier, and a processed_data.csv file with the cell segmentation output (marker intensity expressions) and the cell type label identifier, as used in the publication:</p> <p> </p> <p><strong>Adaptation of Imaging Mass Cytometry to Explore the Single Cell Alloimmune Landscape of Liver Transplant Rejection</strong></p> <p>Nolan Ung, Cameron Goldbeck, Cassandra Man, Julianne Hoeflich, Ren Sun, Arianna Barbetta, Naim Matasci, Jonathan Katz, Jerry S. H. Lee, Shefali Chopra, Shahab Asgharzadeh, Mika Warren, Linda Sher, Rohit Kohli, Omid Akbari, Yuri Genyk and Juliet Emamaullee</p> <p><em>Front. Immunol.</em> 13:831103</p> <p><a href="https://doi.org/10.3389/fimmu.2022.831103">https://doi.org/10.3389/fimmu.2022.831103</a></p> <p> </p> <p><strong><em>Please cite this article if you re-use any of the data.</em></strong></p> <p>"Ung N, Goldbeck C, Man C, Hoeflich J, Sun R, Barbetta A, Matasci N, Katz J, Lee JSH, Chopra S, Asgharzadeh S, Warren M, Sher L, Kohli R, Akbari O, Genyk Y and Emamaullee J (2022) Adaptation of Imaging Mass Cytometry to Explore the Single Cell Alloimmune Landscape of Liver Transplant Rejection. <em>Front. Immunol.</em> 13:831103. doi: 10.3389/fimmu.2022.831103"</p> <p>(https://www.frontiersin.org/articles/10.3389/fimmu.2022.831103/full)</p>
Study of IMC-P115C in Advanced PRAME-Positive Cancers
ClinicalTrials.gov study NCT07156136. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available
ClinicalTrials.gov study NCT00768391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT06535412. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas
ClinicalTrials.gov study NCT04306224. IPD Sharing: NO. Countries: 2. Publications: 0.
IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor
ClinicalTrials.gov study NCT00609141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection
ClinicalTrials.gov study NCT05867056. IPD Sharing: Not stated. Countries: 9. Publications: 0.
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for In
ClinicalTrials.gov study NCT07118085. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab
ClinicalTrials.gov study NCT03973333. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy
ClinicalTrials.gov study NCT00793975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMC-1 In Patients With Fibromyalgia
ClinicalTrials.gov study NCT01850420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
ClinicalTrials.gov study NCT06365840. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.